Analyzing blood components in patients suspected of heparin-induced thrombocytopenia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to analyze platelet and leukocyte activation in patients suspected of having heparin-induced thrombocytopenia (HIT) by quantifying and characterizing these aggregates using in vitro analysis on whole blood samples. The goal is to improve the understanding of the pathophysiology of HIT and reduce reliance on traditional confirmatory tests that have high variability and require specialized facilities. By eliminating the need for platelet donors and minimizing delays in results, this approach could enhance patient management in a serious condition where timely diagnosis is critical.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years
* Any adult patient suspected of having HIT, with a positive anti-PF4/H antibody test
* Patient signed consent to study participation
* Patient with social security coverage

Exclusion Criteria:

* All adult patients with suspected HIT and negative anti-PF4/H antibody test.
* Protected adults (guardianship, under curators) or deprived of liberty

Where it's running

• CHU Amiens
  Amiens, France Recruiting

Study contacts

• Study coordinator: Le Guyader Mailys, Md
• Email: leguyader.mailys@chu-amiens.fr
• Phone: 03.22.08.70.40

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of cardiopulmonary bypass on platelet lipids and bleeding after cardiac surgery

  This study tests how CPB changes platelet lipid metabolism and procoagulant platelets to see if these changes relate to inflammation and bleeding after cardiac surgery.

  Recruiting Université Catholique de Louvain · Brussels · NCT07630987

• Using blood cell ratios and procalcitonin to predict outcomes for adults with sepsis in the ICU

  This project will test whether routine blood measures—neutrophil-to-lymphocyte-and-platelet ratio, procalcitonin, and total white blood cell count—can help predict outcomes for adults with sepsis in the intensive care unit.

  Recruiting Ain Shams University · Cairo · NCT07200817

• Autologous Cold-Stored Platelets for Complex Cardiac Surgery

  This study tests whether using a patient’s own cold-stored platelets, donated 7–10 days before surgery, improves outcomes for adults undergoing complex cardiac procedures compared with standard allogeneic platelets.

  Recruiting Phase 2/3 University Health Network, Toronto · Toronto, Ontario · NCT07064954

• Using a device to recover platelets during cardiac surgery

  This study tests if a special device that collects and returns your own blood during heart surgery can help keep your platelet levels up and reduce the need for blood transfusions.

  Recruiting University Hospital, Strasbourg, France · Strasbourg, Bas-Rhin · NCT06629311

• How complex thoraco‑abdominal aortic aneurysm repair affects blood clotting and platelets

  This will see if complex thoraco‑abdominal aortic aneurysm repair causes changes in blood clotting and platelet activation in patients immediately after surgery.

  Recruiting University of Thessaly · Larissa, Thessaly and 1 other locations · NCT06432387

• Group O leukocyte‑free whole blood: storage effects and inflammation

  This project tests whether group O leukocyte‑free whole blood (LTOWB) causes different inflammatory and biological changes than standard separated blood products using donations from healthy adult blood donors.

  Recruiting Etablissement Français du Sang · Saint-Etienne · NCT06809010

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.